Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Assets Average (2022 - 2025)

Historic Assets Average for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $8.1 million.

  • bioAffinity Technologies' Assets Average rose 2338.64% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 2338.64%. This contributed to the annual value of $7.4 million for FY2024, which is 2778.16% down from last year.
  • Latest data reveals that bioAffinity Technologies reported Assets Average of $8.1 million as of Q3 2025, which was up 2338.64% from $5.1 million recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Assets Average peaked at $13.1 million during Q4 2022, and registered a low of $5.1 million during Q2 2025.
  • For the 4-year period, bioAffinity Technologies' Assets Average averaged around $8.4 million, with its median value being $8.1 million (2024).
  • Its Assets Average has fluctuated over the past 5 years, first tumbled by 3071.14% in 2024, then soared by 2338.64% in 2025.
  • Over the past 4 years, bioAffinity Technologies' Assets Average (Quarter) stood at $13.1 million in 2022, then dropped by 29.85% to $9.2 million in 2023, then dropped by 29.03% to $6.5 million in 2024, then grew by 24.73% to $8.1 million in 2025.
  • Its last three reported values are $8.1 million in Q3 2025, $5.1 million for Q2 2025, and $6.0 million during Q1 2025.